Paraneoplastic leukemoid reaction: Case report and review of the literature

被引:11
作者
Abukhiran, Ibrahim [1 ,2 ]
Mott, Sarah L. [2 ,3 ]
Bellizzi, Andrew M. [1 ,2 ]
Boukhar, Sarag A. [1 ,2 ]
机构
[1] Univ Iowa Hosp & Clin, Dept Pathol, 200 Hawkins Dr, Iowa City, IA 52242 USA
[2] Carver Coll Med, Iowa City, IA USA
[3] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA
关键词
Paraneoplastic leukemoid reaction; Hyperleukocytosis; G-CSF; Neutrophilic stroma;
D O I
10.1016/j.prp.2020.153295
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: We recently encountered a patient with unexplained hyperleukocytosis (105.4 K/mu L at presentation), subsequently found to have colon cancer with a marked tumor-associated neutrophilic infiltrate; the leukocytosis abruptly improved after tumor removal. Paraneoplastic leukemoid reaction (PLR) is a rare entity, occurring due to tumor cytokine secretion (typically granulocyte-colony stimulating factor [G-CSF]). We describe a case and aggregate results of previously published cases. Methods: We reviewed the English-language literature for all prior reports of PLR, recording age, gender, histologic diagnosis, WBC count, G-CSF level, and overall survival. We analyzed clinicopathologic variables' impact on survival. Results: We identified 179 cases (mean age 64; 72 % M). Adeno-, squamous cell, sarcomatoid, and undifferentiated carcinomas accounted for >70 %. Esophagus, gallbladder, lung, liver, and pancreas were the most common primaries. At time of publication 81 % of patients had died, with mean overall survival of 4 months. There was no correlation between WBC count and G-CSF level. On univariate analysis, WBC count was the only variable associated with survival (P = 0.03). Patients with WBC counts >100 K/mu L were twice as likely to die as those with counts from 11 K to 40 K/mu L. Conclusions: PLR, typically carcinoma-associated, is characterized by dismal prognosis. The WBC count is inversely related to survival. Knowledge of this phenomenon militates against protracted, expensive work ups. In malignant neoplasms with prominent neutrophilic stroma, the pathologist should correlate with the WBC count and, if markedly elevated (>40 K/mu L), raise consideration for PLR.
引用
收藏
页数:9
相关论文
共 104 条
[1]   Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours [J].
Abukhiran, Ibrahim A. ;
Jasser, Judy ;
Syrbu, Sergei .
JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (06) :310-313
[2]  
Ahn Heui June, 2005, Korean Journal of Internal Medicine, V20, P247
[3]   Carcinosarcoma of the liver producing granulocyte-colony stimulating factor [J].
Aita, Kumi ;
Seki, Kunihiko .
PATHOLOGY INTERNATIONAL, 2006, 56 (07) :413-419
[4]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[5]  
ASANO S, 1977, BLOOD, V49, P845
[6]  
BERDEL WE, 1989, BLOOD, V73, P80
[7]   A prospective multicenter study on fever of unknown origin - The yield of a structured diagnostic protocol [J].
Bleeker-Rovers, Chantal P. ;
Vos, Fidel J. ;
de Kleijn, Elisabeth M. H. A. ;
Mudde, Aart H. ;
Dofferhoff, Ton S. M. ;
Richter, Clemens ;
Smilde, Tineke J. ;
Krabbe, Paul F. M. ;
Oyen, Wim J. G. ;
van der Meer, Jos W. M. .
MEDICINE, 2007, 86 (01) :26-38
[8]   Paraneoplastic Leukemoid Reaction in Solid Tumors [J].
Chakraborty, Subhankar ;
Keenportz, Brent ;
Woodward, Suzette ;
Anderson, Jay ;
Colan, David .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (03) :326-330
[9]   Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer [J].
Chen, Ming-Huang ;
Chang, Peter Mu-Hsin ;
Chen, Po-Min ;
Tzeng, Cheng-Hwai ;
Chu, Pen-Yuan ;
Chang, Shyue-Yih ;
Yang, Muh-Hwa .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) :1783-1790
[10]   Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy [J].
Choueiri, Toni K. ;
Garcia, Jorge A. ;
Elson, Paul ;
Khasawneh, Mohamad ;
Usman, Saif ;
Golshayan, Ali Reza ;
Baz, Rachid C. ;
Wood, Laura ;
Rini, Brian I. ;
Bukowski, Ronald M. .
CANCER, 2007, 110 (03) :543-550